INSTITUTE OF BIOMED RESH (MRES) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 131 197 sessions, October 24, 2025 to October 26, 2026
- Largest daily move
- +85.7% close of January 22, 2026
- 1-year change
- -82.4% closing prices, October 24, 2025 to October 26, 2026
- 1-month change
- -31.8% closing prices, September 25, 2026 to October 26, 2026
Company Description
INSTITUTE OF BIOMED RESH (OTC: MRES) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $18.4M.
MRES has declined 82.4% over the past year. The last closing price was $0.0015.
This page collects what Stock Titan holds for MRES, including price data, latest news, and short interest trends.
Stock Performance
INSTITUTE OF BIOMED RESH (MRES) closed at $0.0015 on October 26, 2026. Over the past 12 months, the price has lost 82.4%.
MRES Metrics & Rankings
Price returns through October 26, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
INSTITUTE OF BIOMED RESH has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition. View all MRES news →
SEC Filings
Short Interest History
Short interest in INSTITUTE OF BIOMED RESH (MRES) currently stands at 61.0 thousand shares, down 46.5% from the previous reporting period, representing 0.0% of the float. Since November 2025, short interest has increased by 1788.7%.
Days to Cover History
Days to cover for INSTITUTE OF BIOMED RESH (MRES) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
MRES Company Profile & Sector Positioning
INSTITUTE OF BIOMED RESH (MRES) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing MRES often look at related companies in the same sector, including RAPID DOSE THERAPEUTICS (RDTCF), FINCH THERAPEUTCS GRP INC (FNCH), BIOMIND LABS INC (BMNDF), PHARMATHER HLDGS LTD (PHRRF), and ONCOTELIC THERAPEUTCS INC (OTLC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MRES's relative position within its industry.